19592485_1|19592485|107|#section_info|0:0|Confocal imaging of apical surface NKCC2 in isolated perfused TALs confirmed a stimulatory effect of cAMP on apical trafficking that was blocked by PKA inhibition. |#main_body|GO:0016324|apical plasma membrane|#go_definition|IDA|GOA|Slc12a1(25065)|#gene_synonym
0.74	19592485_14|19592485|3074|abstract|0:0|We hypothesized that cAMP increases steady-state surface NKCC2 expression in native TALs by stimulating apical exocytosis and that PKA mediates this process.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	19592485_124|19592485|26345|DISCUSSION|0:0|In addition, we observed that during PKA inhibition with H-89, the Epac-selective agonist decreased surface NKCC2 by 20% (data not shown), suggesting an inhibitory role of Epac in NKCC2 trafficking to the membrane that may be masked by low PKA activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	19592485_125|19592485|26345|DISCUSSION|0:0|Together, our data indicate that PKA mediates cAMP-induced stimulation of steady-state apical surface NKCC2 in TALs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	19592485_15|19592485|3074|abstract|0:0|Our data show for the first time that cAMP stimulates the rate of NKCC2 exocytosis via PKA and that this trafficking step mediates the increase in steady-state surface NKCC2 in native TALs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	19592485_120|19592485|26345|DISCUSSION|0:0|Here, we observed that PKA inhibition blocks cAMP-induced increases in steady-state surface NKCC2 when cAMP is increased by either forskolin/IBMX or the physiological agonist dDAVP in native TAL epithelium (Figs. 1 and 2).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	19592485_72|19592485|11463|RESULTS|0:0|cAMP Increases Steady-state Apical Surface NKCC2 via PKA in TALs|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	19592485_95|19592485|20501|RESULTS|0:0|Endogenous cAMP stimulates apical membrane exocytosis in isolated perfused TALs as measured by FM1-43 fluorescence.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	19592485_135|19592485|29423|DISCUSSION|0:0|Thus, we speculate that PKA stimulates NKCC2 exocytosis by SNARE-dependent fusion and trafficking to the apical membrane of TALs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19592485_130|19592485|28663|DISCUSSION|0:0|Although our data indicate that cAMP stimulates NKCC2 exocytosis, they do not exclude the possibility that cAMP affects endocytosis and recycling of NKCC2 and that these mechanisms also contribute to enhance apical membrane NKCC2 levels.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19592485_43|19592485|7817|EXPERIMENTAL PROCEDURES|0:0|Confocal Microscopy for Apical Surface NKCC2 in Microperfused TALs|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19592485_96|19592485|20501|RESULTS|0:0|A, representative confocal images of microperfused TALs in the presence of apical FM1-43 (2 mum) before (120 s) and after the addition of vehicle (Basal) or forskolin (20 mum) plus IBMX (0.5 mm) after 600 s. (Only apical membranes in focus are visible as expected from selective apical loading of FM1-43.)|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19592485_11|19592485|3074|abstract|0:0|In the collecting duct epithelium, arginine vasopressin and cAMP stimulate aquaporin-2 exocytic insertion into the apical membrane and enhance water permeability (16) in a process mediated by PKA (17-20).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19592485_110|19592485|25533|RESULTS|0:0|cAMP increases the rate of NKCC2 exocytic insertion via PKA in TALs.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19592485_119|19592485|26345|DISCUSSION|0:0|However, the trafficking steps and the signaling cascade by which cAMP increases apical NKCC2 in epithelial cells were unknown.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19592485_10|19592485|3074|abstract|0:0|In addition to PKA, the Epac isoforms Epac1 and Epac2 are expressed in TALs (15), but their role in NKCC2 trafficking has not been addressed.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19592485_45|19592485|7884|EXPERIMENTAL PROCEDURES|0:0|Apical NKCC2 was measured after labeling NKCC2 in intact microperfused TALs with a rabbit antibody against a predicted extracellular epitope (4) of rat NKCC2 (e-NKCC2) as described (24).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19592485_127|19592485|28663|DISCUSSION|0:0|We also observed constitutive NKCC2 insertion under basal conditions (Fig. 5), suggesting that trafficking of NKCC2 to the apical membrane is a continuous dynamic process rather than an event triggered by cAMP.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19592485_5|19592485|2136|abstract|0:0|As NKCC2 must be in the plasma membrane to mediate NaCl absorption, vesicle trafficking of NKCC2, including exocytic insertion, endocytic retrieval, and recycling to and from the plasma membrane, is likely to play a major role in NKCC2 regulation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19592485_132|19592485|29423|DISCUSSION|0:0|Our previous data indicate that the SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) family of proteins is involved in NKCC2 trafficking because the stimulation of surface NKCC2 by cAMP was blocked by tetanus toxin (6).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19592485_1|19592485|0|paper_title|0:0|cAMP Stimulates Apical Exocytosis of the Renal Na+-K+-2Cl- Cotransporter NKCC2 in the Thick Ascending Limb|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19592485_57|19592485|9782|EXPERIMENTAL PROCEDURES|0:0|Apical exocytosis in microperfused TALs was monitored by measuring FM1-43 fluorescence of apical membranes as described previously for renal collecting ducts (10, 21).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19592485_85|19592485|16955|RESULTS|0:0|PKA- but Not Epac-selective Agonists Increase Steady-state Surface NKCC2 in TALs|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19592485_121|19592485|26345|DISCUSSION|0:0|Consistent with a role of PKA, a PKA-selective agonist stimulated surface NKCC2 to similar levels compared with forskolin/IBMX, whereas the Epac-selective agonist 8-p-chlorophenylthio-2'-O-methyl-cAMP had no effect on surface NKCC2 (Fig. 3).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19592485_122|19592485|26345|DISCUSSION|0:0|The absence of an effect of the Epac analog may indicate that Epac is not involved in the stimulation of surface NKCC2 or that the concentration of agonist was not sufficient to stimulate Epac activity.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19592485_2|19592485|2485|#section_info|0:0|We showed previously that cAMP stimulates NKCC2-dependent NaCl reabsorption by increasing steady-state surface NKCC2 in rat TALs (6). |#main_body|GO:0009986|cell surface|#go_definition|IDA|GOA|Slc12a1(25065)|#gene_synonym
0.85	19592485_118|19592485|26345|DISCUSSION|0:0|We found previously that cAMP stimulates NaCl absorption by TAL by increasing surface NKCC2 levels (6).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	19592485_15|19592485|3074|abstract|0:0|Our data show for the first time that cAMP stimulates the rate of NKCC2 exocytosis via PKA and that this trafficking step mediates the increase in steady-state surface NKCC2 in native TALs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	19592485_14|19592485|3074|abstract|0:0|We hypothesized that cAMP increases steady-state surface NKCC2 expression in native TALs by stimulating apical exocytosis and that PKA mediates this process.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	19592485_4|19592485|1779|abstract|0:0|Hormonal stimulation of intracellular cAMP by arginine vasopressin enhances NaCl absorption in the TAL by stimulating NKCC2-dependent transport (2-5).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	19592485_120|19592485|26345|DISCUSSION|0:0|Here, we observed that PKA inhibition blocks cAMP-induced increases in steady-state surface NKCC2 when cAMP is increased by either forskolin/IBMX or the physiological agonist dDAVP in native TAL epithelium (Figs. 1 and 2).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19592485_125|19592485|26345|DISCUSSION|0:0|Together, our data indicate that PKA mediates cAMP-induced stimulation of steady-state apical surface NKCC2 in TALs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19592485_130|19592485|28663|DISCUSSION|0:0|Although our data indicate that cAMP stimulates NKCC2 exocytosis, they do not exclude the possibility that cAMP affects endocytosis and recycling of NKCC2 and that these mechanisms also contribute to enhance apical membrane NKCC2 levels.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19592485_3|19592485|1779|abstract|0:0|The renal-specific Na+-K+-2Cl- cotransporter NKCC2 is expressed at the apical membrane and in subapical vesicles in the thick ascending limb (TAL)2 of Henle's loop, where it mediates NaCl reabsorption (1).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19592485_25|19592485|5228|EXPERIMENTAL PROCEDURES|0:0|Steady-state Surface NKCC2|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19592485_1|19592485|0|paper_title|0:0|cAMP Stimulates Apical Exocytosis of the Renal Na+-K+-2Cl- Cotransporter NKCC2 in the Thick Ascending Limb|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19592485_45|19592485|7884|EXPERIMENTAL PROCEDURES|0:0|Apical NKCC2 was measured after labeling NKCC2 in intact microperfused TALs with a rabbit antibody against a predicted extracellular epitope (4) of rat NKCC2 (e-NKCC2) as described (24).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19592485_72|19592485|11463|RESULTS|0:0|cAMP Increases Steady-state Apical Surface NKCC2 via PKA in TALs|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19592485_85|19592485|16955|RESULTS|0:0|PKA- but Not Epac-selective Agonists Increase Steady-state Surface NKCC2 in TALs|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19592485_124|19592485|26345|DISCUSSION|0:0|In addition, we observed that during PKA inhibition with H-89, the Epac-selective agonist decreased surface NKCC2 by 20% (data not shown), suggesting an inhibitory role of Epac in NKCC2 trafficking to the membrane that may be masked by low PKA activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19592485_11|19592485|3074|abstract|0:0|In the collecting duct epithelium, arginine vasopressin and cAMP stimulate aquaporin-2 exocytic insertion into the apical membrane and enhance water permeability (16) in a process mediated by PKA (17-20).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19592485_5|19592485|2136|abstract|0:0|As NKCC2 must be in the plasma membrane to mediate NaCl absorption, vesicle trafficking of NKCC2, including exocytic insertion, endocytic retrieval, and recycling to and from the plasma membrane, is likely to play a major role in NKCC2 regulation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19592485_135|19592485|29423|DISCUSSION|0:0|Thus, we speculate that PKA stimulates NKCC2 exocytosis by SNARE-dependent fusion and trafficking to the apical membrane of TALs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19592485_3|19592485|11528|#section_info|0:0|We found that incubating TALs for 30 min with forskolin/IBMX increased steady-state surface NKCC2 by 81 +- 16% (p < 0.05). |#main_body|GO:0016101|diterpenoid metabolic process|#go_definition|IEP|GOA|Slc12a1(25065)|#gene_synonym
0.72	19592485_78|19592485|12966|RESULTS|0:0|B, steady-state surface NKCC2 was measured in rat TAL suspensions incubated for 30 min at 37  C with forskolin/IBMX in the absence or presence of H-89 (10 mum) (n = 10; *, p < 0.05 versus basal conditions).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	19592485_79|19592485|12966|RESULTS|0:0|C, steady-state surface NKCC2 was measured in rat TAL suspensions incubated for 30 min at 37  C with dDAVP (1 mum) in the absence or presence of IBMX (0.5 mm) and H-89 (10 mum) (n = 5; *, p < 0.05 versus basal conditions).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19592485_88|19592485|17836|RESULTS|0:0|A, TALs were treated for 30 min at 37  C with the PKA-selective agonist N6-benzoyl-cAMP (N6-Bnz-cAMP) at 0.5 and 1 mm in the absence and presence of H-89 (10 mum), and steady-state surface NKCC2 was measured (n = 7; *, p < 0.05 versus basal conditions).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19592485_120|19592485|26345|DISCUSSION|0:0|Here, we observed that PKA inhibition blocks cAMP-induced increases in steady-state surface NKCC2 when cAMP is increased by either forskolin/IBMX or the physiological agonist dDAVP in native TAL epithelium (Figs. 1 and 2).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19592485_25|19592485|5228|EXPERIMENTAL PROCEDURES|0:0|Steady-state Surface NKCC2|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19592485_4|19592485|11528|#section_info|0:0|which only weakly stimulated surface NKCC2 |#main_body|GO:0009986|cell surface|#go_definition|IDA|GOA|Slc12a1(25065)|#gene_synonym
0.62	19592485_25|19592485|5228|EXPERIMENTAL PROCEDURES|0:0|Steady-state Surface NKCC2|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19592485_118|19592485|26345|DISCUSSION|0:0|We found previously that cAMP stimulates NaCl absorption by TAL by increasing surface NKCC2 levels (6).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19592485_5|19592485|11528|#section_info|0:0|In control experiments, we found no change in surface NKCC2 when TALs were incubated with either IBMX (14 +- 8%) or H-89 alone (7 +- 8%) (data not shown).|#main_body|GO:0009986|cell surface|#go_definition|IDA|GOA|Slc12a1(25065)|#gene_synonym
0.67	19592485_124|19592485|26345|DISCUSSION|0:0|In addition, we observed that during PKA inhibition with H-89, the Epac-selective agonist decreased surface NKCC2 by 20% (data not shown), suggesting an inhibitory role of Epac in NKCC2 trafficking to the membrane that may be masked by low PKA activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19592485_79|19592485|12966|RESULTS|0:0|C, steady-state surface NKCC2 was measured in rat TAL suspensions incubated for 30 min at 37  C with dDAVP (1 mum) in the absence or presence of IBMX (0.5 mm) and H-89 (10 mum) (n = 5; *, p < 0.05 versus basal conditions).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19592485_88|19592485|17836|RESULTS|0:0|A, TALs were treated for 30 min at 37  C with the PKA-selective agonist N6-benzoyl-cAMP (N6-Bnz-cAMP) at 0.5 and 1 mm in the absence and presence of H-89 (10 mum), and steady-state surface NKCC2 was measured (n = 7; *, p < 0.05 versus basal conditions).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19592485_78|19592485|12966|RESULTS|0:0|B, steady-state surface NKCC2 was measured in rat TAL suspensions incubated for 30 min at 37  C with forskolin/IBMX in the absence or presence of H-89 (10 mum) (n = 10; *, p < 0.05 versus basal conditions).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19592485_83|19592485|15438|RESULTS|0:0|In different experiments, TALs were preincubated with H-89 (10 mum) for 15 min, and then either forskolin/IBMX (Forsk/IBMX + H-89) or vehicle was added to the bath for 30 min.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19592485_82|19592485|15438|RESULTS|0:0|ALs were microdissected from rat kidneys and perfused at 37  C. Either vehicle (Basal) or forskolin (20 mum) and IBMX (0.5 mm) were added to the bath and incubated for 30 min.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19592485_120|19592485|26345|DISCUSSION|0:0|Here, we observed that PKA inhibition blocks cAMP-induced increases in steady-state surface NKCC2 when cAMP is increased by either forskolin/IBMX or the physiological agonist dDAVP in native TAL epithelium (Figs. 1 and 2).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19592485_46|19592485|7884|EXPERIMENTAL PROCEDURES|0:0|After treatment of perfused TALs with vehicle or drugs in the absence or presence of H-89 (10 mum) at 37  C, protein trafficking was stopped by cooling TAL cells to 4  C, and apical membranes were labeled with anti-e-NKCC2 antibody (1:100 in 2.5% bovine serum albumin, pH 7.6) added to the lumen perfusate for 30 min at 4  C. The lumen was washed, and TALs were fixed while at 4  C with 4% paraformaldehyde in phosphate-buffered saline.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19592485_111|19592485|25533|RESULTS|0:0|TALs were masked with NHS-acetate and incubated at 37  C for 30 min with either vehicle or forskolin (20 mum) plus IBMX (0.5 mm) in the presence or absence of H-89 (10 mum).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19592485_6|19592485|11528|#section_info|0:0|We observed that a 30-min incubation with 1 mum dDAVP increased surface NKCC2 by 23 +- 9% (p < 0.05). |#main_body|GO:0009986|cell surface|#go_definition|IDA|GOA|Slc12a1(25065)|#gene_synonym
0.73	19592485_79|19592485|12966|RESULTS|0:0|C, steady-state surface NKCC2 was measured in rat TAL suspensions incubated for 30 min at 37  C with dDAVP (1 mum) in the absence or presence of IBMX (0.5 mm) and H-89 (10 mum) (n = 5; *, p < 0.05 versus basal conditions).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19592485_78|19592485|12966|RESULTS|0:0|B, steady-state surface NKCC2 was measured in rat TAL suspensions incubated for 30 min at 37  C with forskolin/IBMX in the absence or presence of H-89 (10 mum) (n = 10; *, p < 0.05 versus basal conditions).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19592485_120|19592485|26345|DISCUSSION|0:0|Here, we observed that PKA inhibition blocks cAMP-induced increases in steady-state surface NKCC2 when cAMP is increased by either forskolin/IBMX or the physiological agonist dDAVP in native TAL epithelium (Figs. 1 and 2).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19592485_88|19592485|17836|RESULTS|0:0|A, TALs were treated for 30 min at 37  C with the PKA-selective agonist N6-benzoyl-cAMP (N6-Bnz-cAMP) at 0.5 and 1 mm in the absence and presence of H-89 (10 mum), and steady-state surface NKCC2 was measured (n = 7; *, p < 0.05 versus basal conditions).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19592485_124|19592485|26345|DISCUSSION|0:0|In addition, we observed that during PKA inhibition with H-89, the Epac-selective agonist decreased surface NKCC2 by 20% (data not shown), suggesting an inhibitory role of Epac in NKCC2 trafficking to the membrane that may be masked by low PKA activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19592485_7|19592485|11528|#section_info|0:0|We found that incubating TALs for 30 min with forskolin/IBMX increased steady-state surface NKCC2 by 81 +- 16% (p < 0.05). |#main_body|GO:0016101|diterpenoid metabolic process|#go_definition|IEP|GOA|Slc12a1(25065)|#gene_synonym
0.72	19592485_78|19592485|12966|RESULTS|0:0|B, steady-state surface NKCC2 was measured in rat TAL suspensions incubated for 30 min at 37  C with forskolin/IBMX in the absence or presence of H-89 (10 mum) (n = 10; *, p < 0.05 versus basal conditions).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	19592485_79|19592485|12966|RESULTS|0:0|C, steady-state surface NKCC2 was measured in rat TAL suspensions incubated for 30 min at 37  C with dDAVP (1 mum) in the absence or presence of IBMX (0.5 mm) and H-89 (10 mum) (n = 5; *, p < 0.05 versus basal conditions).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19592485_88|19592485|17836|RESULTS|0:0|A, TALs were treated for 30 min at 37  C with the PKA-selective agonist N6-benzoyl-cAMP (N6-Bnz-cAMP) at 0.5 and 1 mm in the absence and presence of H-89 (10 mum), and steady-state surface NKCC2 was measured (n = 7; *, p < 0.05 versus basal conditions).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19592485_120|19592485|26345|DISCUSSION|0:0|Here, we observed that PKA inhibition blocks cAMP-induced increases in steady-state surface NKCC2 when cAMP is increased by either forskolin/IBMX or the physiological agonist dDAVP in native TAL epithelium (Figs. 1 and 2).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19592485_25|19592485|5228|EXPERIMENTAL PROCEDURES|0:0|Steady-state Surface NKCC2|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19592485_8|19592485|11528|#section_info|0:0|We found that incubating TALs for 30 min with forskolin/IBMX increased steady-state surface NKCC2 by 81 +- 16% (p < 0.05). |#main_body|GO:0016101|diterpenoid metabolic process|#go_definition|IEP|GOA|Slc12a1(25065)|#gene_synonym
0.72	19592485_78|19592485|12966|RESULTS|0:0|B, steady-state surface NKCC2 was measured in rat TAL suspensions incubated for 30 min at 37  C with forskolin/IBMX in the absence or presence of H-89 (10 mum) (n = 10; *, p < 0.05 versus basal conditions).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	19592485_79|19592485|12966|RESULTS|0:0|C, steady-state surface NKCC2 was measured in rat TAL suspensions incubated for 30 min at 37  C with dDAVP (1 mum) in the absence or presence of IBMX (0.5 mm) and H-89 (10 mum) (n = 5; *, p < 0.05 versus basal conditions).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19592485_88|19592485|17836|RESULTS|0:0|A, TALs were treated for 30 min at 37  C with the PKA-selective agonist N6-benzoyl-cAMP (N6-Bnz-cAMP) at 0.5 and 1 mm in the absence and presence of H-89 (10 mum), and steady-state surface NKCC2 was measured (n = 7; *, p < 0.05 versus basal conditions).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19592485_120|19592485|26345|DISCUSSION|0:0|Here, we observed that PKA inhibition blocks cAMP-induced increases in steady-state surface NKCC2 when cAMP is increased by either forskolin/IBMX or the physiological agonist dDAVP in native TAL epithelium (Figs. 1 and 2).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19592485_25|19592485|5228|EXPERIMENTAL PROCEDURES|0:0|Steady-state Surface NKCC2|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19592485_9|19592485|12966|#section_info|0:0|A, a representative Western blot shows NKCC2 steady-state surface biotinylation in TAL suspensions after 30 min of treatment with vehicle, |#fig_caption|GO:0009986|cell surface|#go_definition|IDA|GOA|Slc12a1(25065)|#gene_synonym
0.67	19592485_24|19592485|5187|EXPERIMENTAL PROCEDURES|0:0|Surface Biotinylation of TAL Suspensions|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19592485_78|19592485|12966|RESULTS|0:0|B, steady-state surface NKCC2 was measured in rat TAL suspensions incubated for 30 min at 37  C with forskolin/IBMX in the absence or presence of H-89 (10 mum) (n = 10; *, p < 0.05 versus basal conditions).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19592485_25|19592485|5228|EXPERIMENTAL PROCEDURES|0:0|Steady-state Surface NKCC2|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19592485_79|19592485|12966|RESULTS|0:0|C, steady-state surface NKCC2 was measured in rat TAL suspensions incubated for 30 min at 37  C with dDAVP (1 mum) in the absence or presence of IBMX (0.5 mm) and H-89 (10 mum) (n = 5; *, p < 0.05 versus basal conditions).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19592485_32|19592485|5255|EXPERIMENTAL PROCEDURES|0:0|Control experiments showed the absence of biotinylation of glyceraldehyde-3-phosphate dehydrogenase in the surface fraction, no change in total NKCC2 with various treatments (see Fig. 1A), linear recovery of biotinylated NKCC2, complete extraction of biotinylated proteins from beads, and a linear range of surface NKCC2 signal in films.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19592485_10|19592485|12966|#section_info|0:0|Surface NKCC2 was detected by Western blotting,|#fig_caption|GO:0009986|cell surface|#go_definition|IDA|GOA|Slc12a1(25065)|#gene_synonym
0.8	19592485_91|19592485|17836|RESULTS|0:0|Surface NKCC2 was detected by Western blotting, and mean optical density was measured by densitometry.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.8	19592485_114|19592485|25533|RESULTS|0:0|Surface NKCC2 was detected by Western blotting, and mean optical density was measured by densitometry.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.77	19592485_31|19592485|5255|EXPERIMENTAL PROCEDURES|0:0|Proteins were resolved on 6% SDS-polyacrylamide gels, and NKCC2 and glyceraldehyde-3-phosphate dehydrogenase were detected by Western blotting.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	19592485_33|19592485|5255|EXPERIMENTAL PROCEDURES|0:0|NKCC2 was detected with chicken anti-rat NKCC2 antibody (1:1400; raised against an N-terminal sequence of rat NKCC2) (6), and glyceraldehyde-3-phosphate dehydrogenase was detected with monoclonal antibodies from Chemicon (Temecula, CA).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19592485_26|19592485|5255|EXPERIMENTAL PROCEDURES|0:0|Biotinylation of TAL surface NKCC2 was performed as described in detail previously (6, 24).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19592485_80|19592485|12966|RESULTS|0:0|After treatment, TALs were cooled to 4  C, and steady-state surface NKCC2 was measured by biotinylation as described under "Experimental Procedures."|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19592485_11|19592485|14407|#section_info|0:0|we found the expected NKCC2 labeling along the apical surface of all TAL cells (Fig. 2A).|#main_body|GO:0016324|apical plasma membrane|#go_definition|IDA|GOA|Slc12a1(25065)|#gene_synonym
0.62	19592485_3|19592485|1779|abstract|0:0|The renal-specific Na+-K+-2Cl- cotransporter NKCC2 is expressed at the apical membrane and in subapical vesicles in the thick ascending limb (TAL)2 of Henle's loop, where it mediates NaCl reabsorption (1).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19592485_62|19592485|9782|EXPERIMENTAL PROCEDURES|0:0|Images were acquired via laser scanning confocal microscopy at a cross-section of labeled TALs along the z axis so that the apical membranes of TAL cells were in focus on both sides of the lumen.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19592485_12|19592485|14407|#section_info|0:0|apical NKCC2 labeling was increased by 75%|#main_body|GO:0016324|apical plasma membrane|#go_definition|IDA|GOA|Slc12a1(25065)|#gene_synonym
0.64	19592485_45|19592485|7884|EXPERIMENTAL PROCEDURES|0:0|Apical NKCC2 was measured after labeling NKCC2 in intact microperfused TALs with a rabbit antibody against a predicted extracellular epitope (4) of rat NKCC2 (e-NKCC2) as described (24).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19592485_13|19592485|14407|#section_info|0:0|apical NKCC2 labeling was increased by 75%|#main_body|GO:0016324|apical plasma membrane|#go_definition|IDA|GOA|Slc12a1(25065)|#gene_synonym
0.64	19592485_45|19592485|7884|EXPERIMENTAL PROCEDURES|0:0|Apical NKCC2 was measured after labeling NKCC2 in intact microperfused TALs with a rabbit antibody against a predicted extracellular epitope (4) of rat NKCC2 (e-NKCC2) as described (24).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19592485_14|19592485|15438|#section_info|0:0|A, representative fluorescent images of apical surface NKCC2 in isolated perfused TALs. |#fig_caption|GO:0016324|apical plasma membrane|#go_definition|IDA|GOA|Slc12a1(25065)|#gene_synonym
0.7	19592485_43|19592485|7817|EXPERIMENTAL PROCEDURES|0:0|Confocal Microscopy for Apical Surface NKCC2 in Microperfused TALs|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19592485_95|19592485|20501|RESULTS|0:0|Endogenous cAMP stimulates apical membrane exocytosis in isolated perfused TALs as measured by FM1-43 fluorescence.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19592485_15|19592485|15438|#section_info|0:0|and apical surface NKCC2 was labeled with a rabbit antibody raised against an extracellular epitope in NKCC2 present in the luminal perfusate as described under "Experimental Procedures."|#fig_caption|GO:0016324|apical plasma membrane|#go_definition|IDA|GOA|Slc12a1(25065)|#gene_synonym
0.83	19592485_45|19592485|7884|EXPERIMENTAL PROCEDURES|0:0|Apical NKCC2 was measured after labeling NKCC2 in intact microperfused TALs with a rabbit antibody against a predicted extracellular epitope (4) of rat NKCC2 (e-NKCC2) as described (24).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	19592485_33|19592485|5255|EXPERIMENTAL PROCEDURES|0:0|NKCC2 was detected with chicken anti-rat NKCC2 antibody (1:1400; raised against an N-terminal sequence of rat NKCC2) (6), and glyceraldehyde-3-phosphate dehydrogenase was detected with monoclonal antibodies from Chemicon (Temecula, CA).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19592485_3|19592485|1779|abstract|0:0|The renal-specific Na+-K+-2Cl- cotransporter NKCC2 is expressed at the apical membrane and in subapical vesicles in the thick ascending limb (TAL)2 of Henle's loop, where it mediates NaCl reabsorption (1).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19592485_43|19592485|7817|EXPERIMENTAL PROCEDURES|0:0|Confocal Microscopy for Apical Surface NKCC2 in Microperfused TALs|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19592485_80|19592485|12966|RESULTS|0:0|After treatment, TALs were cooled to 4  C, and steady-state surface NKCC2 was measured by biotinylation as described under "Experimental Procedures."|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19592485_151|19592485|30988|DISCUSSION|0:0|extracellular NKCC2 epitope|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19592485_5|19592485|2136|abstract|0:0|As NKCC2 must be in the plasma membrane to mediate NaCl absorption, vesicle trafficking of NKCC2, including exocytic insertion, endocytic retrieval, and recycling to and from the plasma membrane, is likely to play a major role in NKCC2 regulation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19592485_46|19592485|7884|EXPERIMENTAL PROCEDURES|0:0|After treatment of perfused TALs with vehicle or drugs in the absence or presence of H-89 (10 mum) at 37  C, protein trafficking was stopped by cooling TAL cells to 4  C, and apical membranes were labeled with anti-e-NKCC2 antibody (1:100 in 2.5% bovine serum albumin, pH 7.6) added to the lumen perfusate for 30 min at 4  C. The lumen was washed, and TALs were fixed while at 4  C with 4% paraformaldehyde in phosphate-buffered saline.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19592485_90|19592485|17836|RESULTS|0:0|After treatment, suspensions were cooled to 4  C, and steady-state surface NKCC2 was measured by biotinylation as described under "Experimental Procedures."|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19592485_16|19592485|15438|#section_info|0:0|A, representative fluorescent images of apical surface NKCC2 in isolated perfused TALs. |#fig_caption|GO:0016324|apical plasma membrane|#go_definition|IDA|GOA|Slc12a1(25065)|#gene_synonym
0.7	19592485_43|19592485|7817|EXPERIMENTAL PROCEDURES|0:0|Confocal Microscopy for Apical Surface NKCC2 in Microperfused TALs|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19592485_95|19592485|20501|RESULTS|0:0|Endogenous cAMP stimulates apical membrane exocytosis in isolated perfused TALs as measured by FM1-43 fluorescence.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19592485_17|19592485|17036|#section_info|0:0|We found that a 30-min incubation with the Epac analog had no effect on surface NKCC2 levels in TALs (Fig. 3). |#main_body|GO:0009986|cell surface|#go_definition|IDA|GOA|Slc12a1(25065)|#gene_synonym
0.67	19592485_121|19592485|26345|DISCUSSION|0:0|Consistent with a role of PKA, a PKA-selective agonist stimulated surface NKCC2 to similar levels compared with forskolin/IBMX, whereas the Epac-selective agonist 8-p-chlorophenylthio-2'-O-methyl-cAMP had no effect on surface NKCC2 (Fig. 3).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19592485_124|19592485|26345|DISCUSSION|0:0|In addition, we observed that during PKA inhibition with H-89, the Epac-selective agonist decreased surface NKCC2 by 20% (data not shown), suggesting an inhibitory role of Epac in NKCC2 trafficking to the membrane that may be masked by low PKA activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19592485_122|19592485|26345|DISCUSSION|0:0|The absence of an effect of the Epac analog may indicate that Epac is not involved in the stimulation of surface NKCC2 or that the concentration of agonist was not sufficient to stimulate Epac activity.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19592485_120|19592485|26345|DISCUSSION|0:0|Here, we observed that PKA inhibition blocks cAMP-induced increases in steady-state surface NKCC2 when cAMP is increased by either forskolin/IBMX or the physiological agonist dDAVP in native TAL epithelium (Figs. 1 and 2).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19592485_15|19592485|3074|abstract|0:0|Our data show for the first time that cAMP stimulates the rate of NKCC2 exocytosis via PKA and that this trafficking step mediates the increase in steady-state surface NKCC2 in native TALs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19592485_78|19592485|12966|RESULTS|0:0|B, steady-state surface NKCC2 was measured in rat TAL suspensions incubated for 30 min at 37  C with forskolin/IBMX in the absence or presence of H-89 (10 mum) (n = 10; *, p < 0.05 versus basal conditions).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19592485_79|19592485|12966|RESULTS|0:0|C, steady-state surface NKCC2 was measured in rat TAL suspensions incubated for 30 min at 37  C with dDAVP (1 mum) in the absence or presence of IBMX (0.5 mm) and H-89 (10 mum) (n = 5; *, p < 0.05 versus basal conditions).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19592485_18|19592485|18848|#section_info|0:0|The trafficking step affected by cAMP and the kinetics of NKCC2 trafficking have not been studied.|#main_body|GO:0006167|AMP biosynthetic process|#go_definition|NONE|GOA|Slc12a1(25065)|#gene_synonym
0.78	19592485_6|19592485|2136|abstract|0:0|Despite its importance, the regulation of NKCC2 trafficking by cAMP has not been thoroughly studied.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19592485_119|19592485|26345|DISCUSSION|0:0|However, the trafficking steps and the signaling cascade by which cAMP increases apical NKCC2 in epithelial cells were unknown.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19592485_10|19592485|3074|abstract|0:0|In addition to PKA, the Epac isoforms Epac1 and Epac2 are expressed in TALs (15), but their role in NKCC2 trafficking has not been addressed.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19592485_15|19592485|3074|abstract|0:0|Our data show for the first time that cAMP stimulates the rate of NKCC2 exocytosis via PKA and that this trafficking step mediates the increase in steady-state surface NKCC2 in native TALs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19592485_127|19592485|28663|DISCUSSION|0:0|We also observed constitutive NKCC2 insertion under basal conditions (Fig. 5), suggesting that trafficking of NKCC2 to the apical membrane is a continuous dynamic process rather than an event triggered by cAMP.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19592485_5|19592485|2136|abstract|0:0|As NKCC2 must be in the plasma membrane to mediate NaCl absorption, vesicle trafficking of NKCC2, including exocytic insertion, endocytic retrieval, and recycling to and from the plasma membrane, is likely to play a major role in NKCC2 regulation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19592485_19|19592485|21917|#section_info|0:0|cAMP Stimulates Exocytic Insertion of NKCC2 in TALs|#main_body|GO:0032978|protein insertion into membrane from inner side|#go_definition|IDA|GOA|Slc12a1(25065)|#gene_synonym
0.81	19592485_110|19592485|25533|RESULTS|0:0|cAMP increases the rate of NKCC2 exocytic insertion via PKA in TALs.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.8	19592485_35|19592485|6741|EXPERIMENTAL PROCEDURES|0:0|Exocytic Insertion of NKCC2|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.77	19592485_108|19592485|24642|RESULTS|0:0|PKA Is Involved in cAMP-stimulated but Not Constitutive Exocytic Insertion of NKCC2|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	19592485_1|19592485|0|paper_title|0:0|cAMP Stimulates Apical Exocytosis of the Renal Na+-K+-2Cl- Cotransporter NKCC2 in the Thick Ascending Limb|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	19592485_93|19592485|18786|RESULTS|0:0|cAMP Stimulates Cumulative Apical Membrane Exocytosis in TALs|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	19592485_72|19592485|11463|RESULTS|0:0|cAMP Increases Steady-state Apical Surface NKCC2 via PKA in TALs|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	19592485_125|19592485|26345|DISCUSSION|0:0|Together, our data indicate that PKA mediates cAMP-induced stimulation of steady-state apical surface NKCC2 in TALs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19592485_15|19592485|3074|abstract|0:0|Our data show for the first time that cAMP stimulates the rate of NKCC2 exocytosis via PKA and that this trafficking step mediates the increase in steady-state surface NKCC2 in native TALs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19592485_11|19592485|3074|abstract|0:0|In the collecting duct epithelium, arginine vasopressin and cAMP stimulate aquaporin-2 exocytic insertion into the apical membrane and enhance water permeability (16) in a process mediated by PKA (17-20).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19592485_14|19592485|3074|abstract|0:0|We hypothesized that cAMP increases steady-state surface NKCC2 expression in native TALs by stimulating apical exocytosis and that PKA mediates this process.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19592485_130|19592485|28663|DISCUSSION|0:0|Although our data indicate that cAMP stimulates NKCC2 exocytosis, they do not exclude the possibility that cAMP affects endocytosis and recycling of NKCC2 and that these mechanisms also contribute to enhance apical membrane NKCC2 levels.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19592485_5|19592485|2136|abstract|0:0|As NKCC2 must be in the plasma membrane to mediate NaCl absorption, vesicle trafficking of NKCC2, including exocytic insertion, endocytic retrieval, and recycling to and from the plasma membrane, is likely to play a major role in NKCC2 regulation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19592485_135|19592485|29423|DISCUSSION|0:0|Thus, we speculate that PKA stimulates NKCC2 exocytosis by SNARE-dependent fusion and trafficking to the apical membrane of TALs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19592485_127|19592485|28663|DISCUSSION|0:0|We also observed constitutive NKCC2 insertion under basal conditions (Fig. 5), suggesting that trafficking of NKCC2 to the apical membrane is a continuous dynamic process rather than an event triggered by cAMP.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19592485_20|19592485|21969|#section_info|0:0|These data show for the first time that cAMP stimulates the rate of NKCC2 exocytic insertion in epithelial cells.|#main_body|GO:0032978|protein insertion into membrane from inner side|#go_definition|IDA|GOA|Slc12a1(25065)|#gene_synonym
0.8	19592485_15|19592485|3074|abstract|0:0|Our data show for the first time that cAMP stimulates the rate of NKCC2 exocytosis via PKA and that this trafficking step mediates the increase in steady-state surface NKCC2 in native TALs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	19592485_130|19592485|28663|DISCUSSION|0:0|Although our data indicate that cAMP stimulates NKCC2 exocytosis, they do not exclude the possibility that cAMP affects endocytosis and recycling of NKCC2 and that these mechanisms also contribute to enhance apical membrane NKCC2 levels.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	19592485_110|19592485|25533|RESULTS|0:0|cAMP increases the rate of NKCC2 exocytic insertion via PKA in TALs.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	19592485_14|19592485|3074|abstract|0:0|We hypothesized that cAMP increases steady-state surface NKCC2 expression in native TALs by stimulating apical exocytosis and that PKA mediates this process.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19592485_11|19592485|3074|abstract|0:0|In the collecting duct epithelium, arginine vasopressin and cAMP stimulate aquaporin-2 exocytic insertion into the apical membrane and enhance water permeability (16) in a process mediated by PKA (17-20).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19592485_127|19592485|28663|DISCUSSION|0:0|We also observed constitutive NKCC2 insertion under basal conditions (Fig. 5), suggesting that trafficking of NKCC2 to the apical membrane is a continuous dynamic process rather than an event triggered by cAMP.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19592485_125|19592485|26345|DISCUSSION|0:0|Together, our data indicate that PKA mediates cAMP-induced stimulation of steady-state apical surface NKCC2 in TALs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19592485_108|19592485|24642|RESULTS|0:0|PKA Is Involved in cAMP-stimulated but Not Constitutive Exocytic Insertion of NKCC2|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19592485_5|19592485|2136|abstract|0:0|As NKCC2 must be in the plasma membrane to mediate NaCl absorption, vesicle trafficking of NKCC2, including exocytic insertion, endocytic retrieval, and recycling to and from the plasma membrane, is likely to play a major role in NKCC2 regulation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19592485_35|19592485|6741|EXPERIMENTAL PROCEDURES|0:0|Exocytic Insertion of NKCC2|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19592485_135|19592485|29423|DISCUSSION|0:0|Thus, we speculate that PKA stimulates NKCC2 exocytosis by SNARE-dependent fusion and trafficking to the apical membrane of TALs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19592485_118|19592485|26345|DISCUSSION|0:0|We found previously that cAMP stimulates NaCl absorption by TAL by increasing surface NKCC2 levels (6).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19592485_21|19592485|22921|#section_info|0:0|TALs were cooled, and newly inserted NKCC2 was biotinylated and detected by Western blotting. |#fig_caption|GO:0032978|protein insertion into membrane from inner side|#go_definition|IDA|GOA|Slc12a1(25065)|#gene_synonym
0.87	19592485_39|19592485|6769|EXPERIMENTAL PROCEDURES|0:0|TALs were then cooled, and newly inserted NKCC2 was biotinylated with NHS-SS-biotin.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.8	19592485_113|19592485|25533|RESULTS|0:0|After treatment, suspensions were cooled down at 4  C, and newly inserted NKCC2 was biotinylated.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	19592485_31|19592485|5255|EXPERIMENTAL PROCEDURES|0:0|Proteins were resolved on 6% SDS-polyacrylamide gels, and NKCC2 and glyceraldehyde-3-phosphate dehydrogenase were detected by Western blotting.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19592485_91|19592485|17836|RESULTS|0:0|Surface NKCC2 was detected by Western blotting, and mean optical density was measured by densitometry.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19592485_114|19592485|25533|RESULTS|0:0|Surface NKCC2 was detected by Western blotting, and mean optical density was measured by densitometry.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19592485_80|19592485|12966|RESULTS|0:0|After treatment, TALs were cooled to 4  C, and steady-state surface NKCC2 was measured by biotinylation as described under "Experimental Procedures."|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19592485_33|19592485|5255|EXPERIMENTAL PROCEDURES|0:0|NKCC2 was detected with chicken anti-rat NKCC2 antibody (1:1400; raised against an N-terminal sequence of rat NKCC2) (6), and glyceraldehyde-3-phosphate dehydrogenase was detected with monoclonal antibodies from Chemicon (Temecula, CA).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19592485_90|19592485|17836|RESULTS|0:0|After treatment, suspensions were cooled to 4  C, and steady-state surface NKCC2 was measured by biotinylation as described under "Experimental Procedures."|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19592485_22|19592485|22921|#section_info|0:0|Constitutive NKCC2 insertion over time was observed after masking surface-accessible sites with NHS-acetate and warming to 37  C for 0, 15, 30, and 45 min.|#fig_caption|GO:0051205|protein insertion into membrane|#go_definition|IDA|GOA|Slc12a1(25065)|#gene_synonym
0.67	19592485_38|19592485|6769|EXPERIMENTAL PROCEDURES|0:0|The drugs for treatment were added at 4  C, and samples were warmed to 37  C. Exocytosed NKCC2 was chased for 15, 30, and 45 min.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19592485_40|19592485|6769|EXPERIMENTAL PROCEDURES|0:0|The efficiency of NHS-acetate masking for NKCC2 was calculated in every experiment from the difference between a TAL aliquot that was not masked with NHS-acetate (100% basal surface NKCC2) and an aliquot that was masked at 4  C but never warmed to 37  C (0 time point).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19592485_23|19592485|24726|#section_info|0:0|These data indicate that PKA is involved in cAMP-stimulated NKCC2 exocytosis but not in constitutive NKCC2 insertion into the apical membrane.|#main_body|GO:0032978|protein insertion into membrane from inner side|#go_definition|IDA|GOA|Slc12a1(25065)|#gene_synonym
0.8	19592485_108|19592485|24642|RESULTS|0:0|PKA Is Involved in cAMP-stimulated but Not Constitutive Exocytic Insertion of NKCC2|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.8	19592485_135|19592485|29423|DISCUSSION|0:0|Thus, we speculate that PKA stimulates NKCC2 exocytosis by SNARE-dependent fusion and trafficking to the apical membrane of TALs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.79	19592485_14|19592485|3074|abstract|0:0|We hypothesized that cAMP increases steady-state surface NKCC2 expression in native TALs by stimulating apical exocytosis and that PKA mediates this process.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.78	19592485_130|19592485|28663|DISCUSSION|0:0|Although our data indicate that cAMP stimulates NKCC2 exocytosis, they do not exclude the possibility that cAMP affects endocytosis and recycling of NKCC2 and that these mechanisms also contribute to enhance apical membrane NKCC2 levels.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.77	19592485_125|19592485|26345|DISCUSSION|0:0|Together, our data indicate that PKA mediates cAMP-induced stimulation of steady-state apical surface NKCC2 in TALs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.76	19592485_15|19592485|3074|abstract|0:0|Our data show for the first time that cAMP stimulates the rate of NKCC2 exocytosis via PKA and that this trafficking step mediates the increase in steady-state surface NKCC2 in native TALs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.75	19592485_5|19592485|2136|abstract|0:0|As NKCC2 must be in the plasma membrane to mediate NaCl absorption, vesicle trafficking of NKCC2, including exocytic insertion, endocytic retrieval, and recycling to and from the plasma membrane, is likely to play a major role in NKCC2 regulation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.75	19592485_11|19592485|3074|abstract|0:0|In the collecting duct epithelium, arginine vasopressin and cAMP stimulate aquaporin-2 exocytic insertion into the apical membrane and enhance water permeability (16) in a process mediated by PKA (17-20).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.75	19592485_127|19592485|28663|DISCUSSION|0:0|We also observed constitutive NKCC2 insertion under basal conditions (Fig. 5), suggesting that trafficking of NKCC2 to the apical membrane is a continuous dynamic process rather than an event triggered by cAMP.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	19592485_110|19592485|25533|RESULTS|0:0|cAMP increases the rate of NKCC2 exocytic insertion via PKA in TALs.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	19592485_72|19592485|11463|RESULTS|0:0|cAMP Increases Steady-state Apical Surface NKCC2 via PKA in TALs|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	19592485_124|19592485|26345|DISCUSSION|0:0|In addition, we observed that during PKA inhibition with H-89, the Epac-selective agonist decreased surface NKCC2 by 20% (data not shown), suggesting an inhibitory role of Epac in NKCC2 trafficking to the membrane that may be masked by low PKA activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	19592485_128|19592485|28663|DISCUSSION|0:0|It is likely that constitutive endocytosis and recycling are involved in maintaining steady-state NKCC2 at the apical membrane.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	19592485_1|19592485|0|paper_title|0:0|cAMP Stimulates Apical Exocytosis of the Renal Na+-K+-2Cl- Cotransporter NKCC2 in the Thick Ascending Limb|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	19592485_3|19592485|1779|abstract|0:0|The renal-specific Na+-K+-2Cl- cotransporter NKCC2 is expressed at the apical membrane and in subapical vesicles in the thick ascending limb (TAL)2 of Henle's loop, where it mediates NaCl reabsorption (1).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19592485_93|19592485|18786|RESULTS|0:0|cAMP Stimulates Cumulative Apical Membrane Exocytosis in TALs|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19592485_120|19592485|26345|DISCUSSION|0:0|Here, we observed that PKA inhibition blocks cAMP-induced increases in steady-state surface NKCC2 when cAMP is increased by either forskolin/IBMX or the physiological agonist dDAVP in native TAL epithelium (Figs. 1 and 2).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19592485_35|19592485|6741|EXPERIMENTAL PROCEDURES|0:0|Exocytic Insertion of NKCC2|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19592485_10|19592485|3074|abstract|0:0|In addition to PKA, the Epac isoforms Epac1 and Epac2 are expressed in TALs (15), but their role in NKCC2 trafficking has not been addressed.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19592485_132|19592485|29423|DISCUSSION|0:0|Our previous data indicate that the SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) family of proteins is involved in NKCC2 trafficking because the stimulation of surface NKCC2 by cAMP was blocked by tetanus toxin (6).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19592485_12|19592485|3074|abstract|0:0|However, Epac-selective agonists also enhance aquaporin-2 trafficking and apical exocytosis in this renal epithelium, suggesting a role for Epac1 (10, 21).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19592485_45|19592485|7884|EXPERIMENTAL PROCEDURES|0:0|Apical NKCC2 was measured after labeling NKCC2 in intact microperfused TALs with a rabbit antibody against a predicted extracellular epitope (4) of rat NKCC2 (e-NKCC2) as described (24).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19592485_85|19592485|16955|RESULTS|0:0|PKA- but Not Epac-selective Agonists Increase Steady-state Surface NKCC2 in TALs|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19592485_95|19592485|20501|RESULTS|0:0|Endogenous cAMP stimulates apical membrane exocytosis in isolated perfused TALs as measured by FM1-43 fluorescence.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19592485_131|19592485|29423|DISCUSSION|0:0|The protein targets by which PKA stimulates NKCC2 exocytosis are not known.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19592485_43|19592485|7817|EXPERIMENTAL PROCEDURES|0:0|Confocal Microscopy for Apical Surface NKCC2 in Microperfused TALs|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19592485_118|19592485|26345|DISCUSSION|0:0|We found previously that cAMP stimulates NaCl absorption by TAL by increasing surface NKCC2 levels (6).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19592485_56|19592485|9723|EXPERIMENTAL PROCEDURES|0:0|Real-time Monitoring of Apical Membrane Exocytosis in TALs|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19592485_121|19592485|26345|DISCUSSION|0:0|Consistent with a role of PKA, a PKA-selective agonist stimulated surface NKCC2 to similar levels compared with forskolin/IBMX, whereas the Epac-selective agonist 8-p-chlorophenylthio-2'-O-methyl-cAMP had no effect on surface NKCC2 (Fig. 3).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19592485_24|19592485|27807|#section_info|0:0|In our experiments, 10 mum H-89 blocked 70-100% of the forskolin/IBMX effect in steady-state apical NKCC2 (Figs. 1 and 2). |#main_body|GO:0016324|apical plasma membrane|#go_definition|IDA|GOA|Slc12a1(25065)|#gene_synonym
0.67	19592485_120|19592485|26345|DISCUSSION|0:0|Here, we observed that PKA inhibition blocks cAMP-induced increases in steady-state surface NKCC2 when cAMP is increased by either forskolin/IBMX or the physiological agonist dDAVP in native TAL epithelium (Figs. 1 and 2).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19592485_73|19592485|11528|RESULTS|0:0|reincubation of TALs with the PKA inhibitor H-89 (10 mum) blocked 70% of the forskolin/IBMX effect, p < 0.05 versus forskolin/IBMX) (Fig. 1, A and B).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19592485_79|19592485|12966|RESULTS|0:0|C, steady-state surface NKCC2 was measured in rat TAL suspensions incubated for 30 min at 37  C with dDAVP (1 mum) in the absence or presence of IBMX (0.5 mm) and H-89 (10 mum) (n = 5; *, p < 0.05 versus basal conditions).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19592485_88|19592485|17836|RESULTS|0:0|A, TALs were treated for 30 min at 37  C with the PKA-selective agonist N6-benzoyl-cAMP (N6-Bnz-cAMP) at 0.5 and 1 mm in the absence and presence of H-89 (10 mum), and steady-state surface NKCC2 was measured (n = 7; *, p < 0.05 versus basal conditions).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19592485_96|19592485|20501|RESULTS|0:0|A, representative confocal images of microperfused TALs in the presence of apical FM1-43 (2 mum) before (120 s) and after the addition of vehicle (Basal) or forskolin (20 mum) plus IBMX (0.5 mm) after 600 s. (Only apical membranes in focus are visible as expected from selective apical loading of FM1-43.)|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
